Healthequity Inc (HQY) VP Darcy G. Mott Sells 9,500 Shares

Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $55.19, for a total value of $524,305.00. Following the completion of the sale, the vice president now directly owns 102,500 shares in the company, valued at $5,656,975. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Healthequity Inc (NASDAQ:HQY) traded down $5.97 during midday trading on Friday, hitting $50.74. The stock had a trading volume of 1,268,500 shares, compared to its average volume of 594,701. The firm has a market cap of $3,050.00, a price-to-earnings ratio of 68.17, a P/E/G ratio of 2.16 and a beta of 1.70. Healthequity Inc has a fifty-two week low of $37.62 and a fifty-two week high of $57.72.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company’s revenue was up 31.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 EPS. research analysts forecast that Healthequity Inc will post 0.73 earnings per share for the current year.

A number of analysts have issued reports on the company. Cantor Fitzgerald raised their price target on Healthequity from $56.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 7th. Robert W. Baird lifted their price objective on Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a research note on Wednesday, February 7th. BidaskClub raised Healthequity from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a research note on Wednesday, November 8th. Finally, Chardan Capital lifted their price objective on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, December 6th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $56.67.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Zions Bancorporation purchased a new stake in shares of Healthequity during the 3rd quarter valued at about $119,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Healthequity during the 4th quarter valued at about $149,000. CIBC Asset Management Inc purchased a new stake in shares of Healthequity during the 3rd quarter valued at about $208,000. Two Sigma Securities LLC purchased a new stake in shares of Healthequity during the 4th quarter valued at about $208,000. Finally, Ameritas Investment Partners Inc. raised its holdings in shares of Healthequity by 17.4% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock valued at $218,000 after buying an additional 648 shares during the period. 99.47% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was first published by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://weekherald.com/2018/02/23/healthequity-inc-hqy-vp-darcy-g-mott-sells-9500-shares.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply